THB 3,682.20 million in 1Q2020, representing a decrease of THB 283.81 million or 7.16% down from 1Q2019 mainly from lower revenue of farm business which decreased by THB 123.30 million or 9.01% down
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
) that grew by 18% Q-o-Q and 81% Y-o-Y (Table 5), which on the other hand caused a reduction in production efficiency. Furthermore, as total production volume decreased, product costs rose, all of which
quarter of 2018 (“3Q’18”) was THB 427 million, increased 9% yoy. Non-social security yoy revenue growth was highly 18% while social security revenue growth slightly decreased. Non-social security’s
profit margin (%) 3.54% (0.71%) 4.24% 1. Total Revenue Total revenue in Q120 was Baht 208.21 million, decreased by 16.21% QOQ as a result of economy slowdown, the Coronavirus disease 2019 (COVID-19), and
Utilities and Power Business and as a result improved the Company’s performance compared to 2016 Par spliting from Baht 5 to Baht 1 started July 13, 2017. The Company issued the 3-Year debentures to
%. The Company would like to clarify significant changes in the Group’s operating results are as follows: 1. Revenues from sales and services for the six-month period of 2017 decreased 19% compared to the
%. The Company would like to clarify significant changes in the Group’s operating results are as follows: 1. Revenues from sales and services for the nine-month period of 2017 decreased 15% compared to the
of 0.96 THB. The company and its subsidiaries recorded total EBITDA of THB 3,580 million (+28% YoY, +42% QoQ), performance improved, especially for the Refinery Business, of which average crude run
products of THB 9,158 million, improved by 50%, recorded EBITDA of THB 225 million, slightly down 2% and Adjusted EBITDA of THB 507 million, inched up 40% compared to the first 6 months of 2019. Net loss was